| QDEL Snapshot | |
|---|---|
| Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California. | |
| VALUATION DATA | |
| Market Capitalization | $2,729,989,000 | Price to Sales | 2.00 |
| Earnings per Share | $-0.1500 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $40.8200 |
| 52 Week High | $0.941 |
| 52 Week Low | $0.563 |
| 50-Day Moving Average | $1.756 |
| 200-Day Moving Average | $8.68 |
| All data are from Alpha Vantage as of today. For more infomation on QDEL see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search